These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
209 related items for PubMed ID: 14660236
1. Functional outcome following Botulinum toxin A injection to reduce spastic equinus in adults with traumatic brain injury. Fock J, Galea MP, Stillman BC, Rawicki B, Clark M. Brain Inj; 2004 Jan; 18(1):57-63. PubMed ID: 14660236 [Abstract] [Full Text] [Related]
3. Treating spastic equinus foot from cerebral palsy with botulinum toxin type A: what factors influence the results?: an analysis of 189 consecutive cases. Pascual-Pascual SI, Pascual-Castroviejo I, Ruiz PJ. Am J Phys Med Rehabil; 2011 Jul; 90(7):554-63. PubMed ID: 21765274 [Abstract] [Full Text] [Related]
4. Electrical stimulation of antagonist muscles after botulinum toxin type A for post-stroke spastic equinus foot. A randomized single-blind pilot study. Baricich A, Picelli A, Carda S, Smania N, Cisari C, Santamato A, de Sire A, Invernizzi M. Ann Phys Rehabil Med; 2019 Jul; 62(4):214-219. PubMed ID: 31228593 [Abstract] [Full Text] [Related]
6. Spread of botulinum neurotoxin type a at standard doses is inherent to the successful treatment of spastic equinus foot in cerebral palsy: short-term neurophysiological and clinical study. Frasson E, Dall'ora E, Bordignon M, Brigo F, Tocco P, Primon D, Didonè G, Vicentini S, Fiaschi A, Bertolasi L. J Child Neurol; 2012 May; 27(5):587-93. PubMed ID: 22114218 [Abstract] [Full Text] [Related]
7. A pilot study of delayed versus immediate serial casting after botulinum toxin injection for partially reducible spastic equinus. Newman CJ, Kennedy A, Walsh M, O'Brien T, Lynch B, Hensey O. J Pediatr Orthop; 2007 Dec; 27(8):882-5. PubMed ID: 18209608 [Abstract] [Full Text] [Related]
10. Botulinum toxin type A for the treatment of equinus deformity in patients with mucopolysaccharidosis type II. Nava E, Weber P, Gautschi M, Nuoffer JM, Grunt S. J Child Neurol; 2012 Dec; 27(12):1611-5. PubMed ID: 22433425 [Abstract] [Full Text] [Related]
11. A double-blind randomised placebo-controlled evaluation of three doses of botulinum toxin type A (Dysport) in the treatment of spastic equinovarus deformity after stroke. Pittock SJ, Moore AP, Hardiman O, Ehler E, Kovac M, Bojakowski J, Al Khawaja I, Brozman M, Kanovský P, Skorometz A, Slawek J, Reichel G, Stenner A, Timerbaeva S, Stelmasiak Z, Zifko UA, Bhakta B, Coxon E. Cerebrovasc Dis; 2003 Dec; 15(4):289-300. PubMed ID: 12686794 [Abstract] [Full Text] [Related]
13. The effect of injections of botulinum toxin type A combined with casting on the equinus gait of children with cerebral palsy. Hayek S, Gershon A, Wientroub S, Yizhar Z. J Bone Joint Surg Br; 2010 Aug; 92(8):1152-9. PubMed ID: 20675764 [Abstract] [Full Text] [Related]
16. Botulinum toxin type A neuromuscular blockade in the treatment of lower extremity spasticity in cerebral palsy: a randomized, double-blind, placebo-controlled trial. BOTOX Study Group. Koman LA, Mooney JF, Smith BP, Walker F, Leon JM. J Pediatr Orthop; 2000 Aug; 20(1):108-15. PubMed ID: 10641699 [Abstract] [Full Text] [Related]
18. Efficacy of therapeutic ultrasound and transcutaneous electrical nerve stimulation compared with botulinum toxin type A in the treatment of spastic equinus in adults with chronic stroke: a pilot randomized controlled trial. Picelli A, Dambruoso F, Bronzato M, Barausse M, Gandolfi M, Smania N. Top Stroke Rehabil; 2014 Aug; 21 Suppl 1():S8-16. PubMed ID: 24722047 [Abstract] [Full Text] [Related]
20. Effects of botulinum toxin A therapy with electrical stimulation on spastic calf muscles in children with cerebral palsy. Kang BS, Bang MS, Jung SH. Am J Phys Med Rehabil; 2007 Nov; 86(11):901-6. PubMed ID: 17873826 [Abstract] [Full Text] [Related] Page: [Next] [New Search]